Cannabics Pharmaceuticals Buy Hold or Sell Recommendation

CNBX -- USA Stock  

USD 0.34  0.04  13.33%

Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding Cannabics Pharmaceuticals is 'Strong Sell'. Macroaxis provides Cannabics Pharmaceuticals buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding CNBX positions. The advice algorithm takes into account all of Cannabics Pharmaceuticals available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from CNBX buy-and-hold prospective. Check also Cannabics Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Symbol
Execute Advice
Sell Cannabics PharmaceuticalsBuy Cannabics Pharmaceuticals
Strong Sell

Volatility

Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Not Available
For the selected time horizon Cannabics Pharmaceuticals has a mean deviation of 3.46, semi deviation of 3.79, standard deviation of 5.1, variance of 26.02, downside variance of 28.14 and semi variance of 14.36
We provide buy or sell advice to complement the prevailing expert consensus on Cannabics Pharmaceuticals. Our dynamic recommendation engine makes use of multi - dimensional algorithm to analyze the company potential to grow using all technical and fundamental data available at the time. To make sure Cannabics Pharmaceuticals is not overpriced, please confirm all Cannabics Pharmaceuticals fundamentals including its Price to Book, Cash and Equivalents as well as the relationship between Cash and Equivalents and Earnings Per Share . As Cannabics Pharmaceuticals appears to be a penny stock we also recommend to validate its Net Income numbers.

Cannabics Pharmaceuticals Trading Alerts and Improvement Suggestions

Cannabics Pharmaceuticals has very high historical volatility over the last 30 days
Cannabics Pharmaceuticals has some characteristics of a very speculative penny stock
Cannabics Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years
CANNIBICS PHARMAC currently holds about 5.17M in cash with (2.49M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04.

Cannabics Pharmaceuticals Returns Distribution Density

Mean Return0.19Value At Risk7.16
Potential Upside8.14Standard Deviation5.10
 Return Density 
      Distribution 

Cannabics Pharmaceuticals Greeks

α
Alpha over DOW
=0.07
β
Beta against DOW=0.76
σ
Overall volatility
=5.27
Ir
Information ratio =0.0064

Cannabics Pharmaceuticals Volatility Alert

Cannabics Pharmaceuticals shows above average downside volatility of 5.3 for selected time horizon. We advise investors to further inspect Cannabics Pharmaceuticals to make sure all market timing and asset allocation strategies are consistent with estimation about Cannabics Pharmaceuticals future alpha. Cannabics Pharmaceuticals is a potential penny stock. Although Cannabics Pharmaceuticals may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial stock hype. Please make sure you totally understand upside potential and downside risk of investing in Cannabics Pharmaceuticals. We encourage investors to look for the signals such us email spams, message board hypes, claims of breakthroughs, volume upswings,sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on this equity instrument if you perfectly time your entry and exit. However, remember that penny stocks that has been the subject of an artificial hype usually unable to maintain its increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The one and only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
    
 Better Than Average     
    
 Worse Than Average Compare Cannabics Pharmaceuticals to competition

Cannabics Pharmaceuticals Fundamental Vs Peers

FundamentalsCannabics PharmaceuticalsPeer Average
Return On Equity13.85% (0.31)%
Return On Asset(17.64)% (0.14)%
Current Valuation34.5M16.62B
Shares Outstanding134.46M571.82M
Price to Earning24.13X28.72X
Price to Book2.13X9.51X
Revenue11.54K9.43B
Gross Profit9.6K27.38B
EBITDA(2.95M)3.9B
Net Income1.47M570.98M
Cash and Equivalents5.17M2.7B
Cash per Share0.04X5.01X
Current Ratio15.80X2.16X
Book Value Per Share0.14X1.93K
Cash Flow from Operations(2.49M)971.22M
Earnings Per Share0.012X3.12X
Number of Employees818.84K
Beta-3.67-0.15
Market Capitalization37.61M19.03B
Search macroaxis.com